Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

This study has been completed.
Sponsor:
Collaborator:
Conducted under Salus Pharma, Inc.
Information provided by:
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01055847
First received: January 23, 2010
Last updated: January 25, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2004
  Primary Completion Date: August 2004 (Final data collection date for primary outcome measure)